MediWound Q2 Earnings Snapshot
MDWD Stock | USD 16.23 0.25 1.56% |
About 60% of all Mediwound's shareholders are looking to take a long position. The analysis of overall sentiment of trading Mediwound stock suggests that some investors are interested at this time. The current market sentiment, together with Mediwound's historical and current headlines, can help investors time the market. In addition, many technical investors use Mediwound stock news signals to limit their universe of possible portfolio assets.
Mediwound |
YAVNE, Israel MediWound Ltd. on Wednesday reported a loss of 6.3 million in its second quarter. On a per-share basis, the Yavne, Israel-based company said it had a loss of 68 cents. The results fell short of Wall Street expectations.
Read at finance.yahoo.com
![]() |
Mediwound Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Mediwound can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Mediwound Fundamental Analysis
We analyze Mediwound's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mediwound using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mediwound based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Mediwound is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Mediwound Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mediwound stock to make a market-neutral strategy. Peer analysis of Mediwound could also be used in its relative valuation, which is a method of valuing Mediwound by comparing valuation metrics with similar companies.
Peers
Mediwound Related Equities
DYAI | Dyadic International | 6.67 | ||||
MLYS | Mineralys Therapeutics, | 2.89 | ||||
CRNX | Crinetics Pharmaceuticals | 2.82 | ||||
OCUL | Ocular Therapeutix | 2.51 | ||||
INBX | Inhibrx | 2.02 | ||||
LYEL | Lyell Immunopharma | 1.83 | ||||
MRUS | Merus BV | 1.52 | ||||
KROS | Keros Therapeutics | 0.64 | ||||
AVTE | Aerovate Therapeutics | 0.41 | ||||
REPL | Replimune | 0.00 | ||||
SWTX | SpringWorks Therapeutics | 1.35 | ||||
KRON | Kronos Bio | 1.79 | ||||
SNDX | Syndax Pharmaceuticals | 1.86 | ||||
RNA | Avidity Biosciences | 1.92 | ||||
NKTX | Nkarta | 2.22 | ||||
GBIO | Generation Bio | 3.57 | ||||
STRO | Sutro Biopharma | 3.73 | ||||
VCYT | Veracyte | 4.76 | ||||
GLUE | Monte Rosa | 5.71 | ||||
FHTX | Foghorn Therapeutics | 7.58 | ||||
SANA | Sana Biotechnology | 10.07 |
Complementary Tools for Mediwound Stock analysis
When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |